Research and Development

Showing 15 posts of 9600 posts found.

NICE image

Grant NICE greater trial data access – report

May 29, 2013 Research and Development, Sales and Marketing Goldacre, NICE, transparency, trials

A new report by the National Audit Office says NICE should be given greater powers to access clinical trial data. …
Merck image

FDA experts recommend Merck sleep pill

May 24, 2013 Research and Development, Sales and Marketing FDA, Merck, insomnia, suvorexant

Merck received welcome news this week from the FDA after one of the US regulator’s expert groups voted to approve …
janssen image

Janssen outlines pipeline ambitions

May 24, 2013 Research and Development, Sales and Marketing Janssen, Johnson and Johnson, pipeline

Janssen has outlined plans to submit ‘more than ten’ new product filings worldwide in the next four years, along with …
asdasd

Hurel appoints Schering-Plough executive to its Board

May 24, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Hurel, Merck, Schering-Plough

Pre-clinical products firm Hurel has appointed Dr James MacDonald to the company’s Board of directors.  MacDonald is the former executive …

GSK gets $200m from White House

May 23, 2013 Research and Development, Sales and Marketing AMR, BARDA, GSK, HHS, white house

GlaxoSmithKline is to be given up to $200 million by the US government to develop new antibiotics as worries grow …

Bayer hires chief information officer

May 23, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, information

Johannes Schubmehl has been appointed chief information officer of Bayer HealthCare. Schubmehl succeeded Matthias Moritz, who left the company at …
Actavis image

Actavis snaps up Warner Chilcott

May 22, 2013 Research and Development, Sales and Marketing Actavis, Warner Chilcott

Actavis is to buy Dublin-based firm Warner Chilcott in an $8.5 billion deal which will see the Warner name disappear …
ABPI image

ABPI takes on vaccine industry brief

May 22, 2013 Research and Development ABPI, vaccines

The ABPI is to take on responsibility for representing the vaccine industry to UK government and healthcare stakeholders.For more than …
pfizerworld

Pfizer abandons cancer trial

May 22, 2013 Research and Development, Sales and Marketing Cancer, Inotuzumab ozogamicin, Pfizer, oncology

Pfizer’s oncology pipeline has suffered a blow with the company abandoning a Phase III study of one of its investigational …
wefwefwefw

Board changes at Boehringer Ingelheim

May 22, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, baiker

Boehringer’s Professor Wolfram Carius is stepping down from the Board to be replaced by Dr Wolfgang Baiker. Carius who is …
eisai_ricardo_gonzalez_-balboa-90-2-1368715273mr

New general manager for Eisai in Mexico

May 21, 2013 Manufacturing and Production, Research and Development, Sales and Marketing

Eisai has appointed Ricardo Gonzalez Balboa to the position of general manager, Eisai Mexico. In this position, Gonzalez Balboa will …
NHS image

Working with the NHS in austerity

May 20, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, atkin, austerity, reforms, wellards

The National Health Service, perhaps the UK’s most deeply loved institution, is facing a double threat. On one hand, there …

Promise for Lundbeck and Takeda’s depression drug

May 20, 2013 Research and Development, Sales and Marketing Lexapro, Lundbeck, Takeda, cymbalta, depression, lilly

Takeda and Lundbeck’s treatment for major depressive disorder has demonstrated a significant improvement in patients’ symptoms during trials. Brintellix (Vortioxetine) …
kela-madar

Biotec Services expands presence in Israel

May 20, 2013 Research and Development, Sales and Marketing Biotec

Clinical supplies firm Biotec Services International has expanded its presence in Israel with the appointment of a new Israeli agent. …
rawlins_nice

NICE chairman joins biotech Board

May 17, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Intra-Cellular Therapies, NICE, Rawlins

Biotech firm Intra-Cellular Therapies has appointed former NICE chairman Professor Sir Michael Rawlins to its Board of directors. Rawlins was …
The Gateway to Local Adoption Series

Latest content